The current institutional shareholding score of Syndax Pharmaceuticals Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 123.04%, representing a quarter-over-quarter increase of 3.63%. The largest institutional shareholder is Steven Cohen, holding a total of 2.37M shares, representing 2.24% of shares outstanding, with 0.04% decrease in holdings.